Discover how groundbreaking brain stimulation technology is giving hope to individuals with paralysis Learn about the ...

The completion of the funding round follows Newronika’s recent receival of an IDE from the FDA for the Parkinson’s therapy ...

Deep brain stimulation (DBS) has shown remarkable therapeutic benefits for patients with otherwise treatment-resistant movement and affective disorders, such as chronic pain, Parkinson's disease ...

Medicare covers deep brain stimulation (DBS) to treat Parkinson’s disease or essential tremor when a doctor deems it medically necessary and when a person meets the coverage criteria.

Newronika, a global leader in advanced deep brain stimulation, is pleased to announce the successful closing of its €13.6 ...

Newronika announced today that it closed a €13.6 million ($14.1 million) Series B round to support its deep brain stimulation ...